secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001213900-24-090366
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio schedules Q3 2024 earnings call for Oct 31 at 4:30pm EDT
-------------------------------------------------------------------

- Press release issued Oct 24, 2024 announcing conference call date.
- Call on Thursday, October 31, 2024 at 4:30pm ET to discuss Q3 results and corporate update.
- Dial-in: 1-800-343-4136 (US), 1-203-518-9843 (intl); Conference ID: INMUNE.
- Webcast and replay available; transcript expected within 24 hours of call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/0001213900-24-090366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/ea0218524-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-090366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer